Healthcare Industry News Weekly Wrap-Up: September 1, 2023
// Biotech and Pharma Therapeutics BMS publishes ‘modest’ multiple myeloma survival data on heir to Revlimid, Pomalyst August 30, 2023 / Bristol Myers Squibb / Multiple Myeloma / Clinical Trial Data Bristol Myers Squibb has reported full phase 1 data...